Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAL |
| Upstream (Parents) |
|---|
| (<<) CCND2 → MAL |
| (<<) CD79A → MAL |
| (<<) CORO1A → MAL |
| (<<) CYR61 → MAL |
| (<<) DOK7 → MAL |
| (<<) EPHA2 → MAL |
| (<<) JAK3 → MAL |
| (<<) KLK10 → MAL |
| (<<) KLK7 → MAL |
| (<<) LTB → MAL |
| (<<) PIK3CD → MAL |
| (<<) PLD3 → MAL |
| (<<) PRKCB → MAL |
| (<<) PRKCH → MAL |
| (<<) RAC2 → MAL |
| (<<) RASSF5 → MAL |
| (<<) RPS16 → MAL |
| (<<) SPRR3 → MAL |
| (<<) VAV1 → MAL |
| Downstream (Children) |
|---|
| MAL → AKT2 (>>) |
| MAL → ASB2 (>>) |
| MAL → CCND3 (>>) |
| MAL → CHST7 (>>) |
| MAL → CXCL14 (>>) |
| MAL → IL1F5 (>>) |
| MAL → IL1R2 (>>) |
| MAL → JMJD6 (>>) |
| MAL → LCP1 (>>) |
| MAL → PCSK7 (>>) |
| MAL → PLOD2 (>>) |
| MAL → SERPINB2 (>>) |
| MAL → TGFA (>>) |
